MUSE

LOE Approaching

alprostadil

NDAURETHRALSUPPOSITORYPriority Review
Approved
Nov 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6

Clinical Trials (5)

NCT06634225N/ACompleted

Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP)

Started Nov 2024
70 enrolled
Multiple SclerosisMedical DeviceCoordination and Balance Disturbances
NCT05236153N/AUnknown

Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot

Started Nov 2022
60 enrolled
Tetralogy of FallotVentricular TachycardiaSudden Cardiac Death
NCT04267939Phase 1Terminated

ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

Started Feb 2020
14 enrolled
Advanced Solid Tumors (Excluding Prostate Cancer)Ovarian Cancer
NCT04095273Phase 1Completed

Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

Started Sep 2019
56 enrolled
Advanced Solid Tumors
NCT00619229Phase 3Terminated

Alprostadil in Maculopathy Study (AIMS)

Started Jul 2006
37 enrolled
Macular Degeneration